Home › Digestive Diseases › Florida › Orlando
Digestive Diseases clinical trials in Orlando, FL
3 studies for Digestive Diseases are looking for participants at sites in and around Orlando (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
RecruitingPhase 3
- 89bio Clinical Study Site, Winter Park · 5 mi away
- 89bio Clinical Study Site, Ocoee · 10 mi away
- 89bio Clinical Study Site, Clermont · 24 mi away
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
RecruitingPhase 3
- 89bio Clinical Study Site, Winter Park · 5 mi away
- 89bio Clinical Study Site, Maitland · 6 mi away
- 89bio Clinical Study Site, Maitland · 6 mi away
- and 2 more
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
RecruitingPhase 2
- Orlando Health Digestive Health Institute, Orlando
- AdventHealth Orlando, Orlando
- Novum Research, LLC, Clermont · 24 mi away
About Digestive Diseases
Learn about digestive disorders and how your gastrointestinal (GI) system works. Find out what tests you need in case you sense a problem.
More about Digestive Diseases on MedlinePlus
Digestive Diseases trials in other cities
- New York City, NY8 studies
- Houston, TX8 studies
- Chicago, IL8 studies
- Washington, DC6 studies
- Durham, NC6 studies
- San Diego, CA6 studies
- Boston, MA6 studies
- Seattle, WA5 studies
- Jacksonville, FL5 studies
- Chandler, AZ5 studies
- Rochester, MN5 studies
- Sarasota, FL5 studies
Other studies in Orlando
- Non-Small Cell Lung Cancer44 studies
- Obesity29 studies
- Metastatic Cancer29 studies
- Alzheimer's Disease25 studies
- Cancer (all types)25 studies
- Overweight25 studies
- Type 2 Diabetes24 studies
- Breast Cancer23 studies
- Ovarian Cancer22 studies
- Ulcerative Colitis22 studies
- Lung Cancer21 studies
- Major Depressive Disorder19 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.